Singapore, 2 June 2025 – Aevice Health today announced that its flagship product, AeviceMD, has been officially granted a patent by the Japan Patent Office (JPO). This milestone strengthens the company’s global intellectual property portfolio and reinforces the originality of its Internet-of-Medical-Things (IoMT) respiratory care technology under Japanese patent law.
The patent covers AeviceMD’s proprietary solution for continuous respiratory monitoring, which supports the early detection of exacerbations, encourages medication adherence, and captures key vital signs such as heart rate and respiratory rate. Designed for both clinical and home use, the device provides clinicians with real-time, actionable insights to deliver more proactive and personalized care.
With intellectual property protections now established in Japan, Aevice Health is well-positioned to deepen strategic partnerships and explore new collaborations across the region. The patent grant marks a significant step in the company’s broader efforts to expand access to its remote monitoring solutions in key global healthcare markets.
“This patent grant represents a key milestone in the strategic expansion of our global IP portfolio and aligns with Aevice Health’s long-term roadmap to protect and commercialize our core technologies in priority markets. It highlights our differentiated capabilities in developing clinically validated, connected respiratory monitoring solutions that address critical gaps in chronic disease management. With formal IP protection now secured in Japan, we are well-positioned to accelerate regional market access, deepen B2B partnerships, and scale our platform as a standard of care in both acute and home-based settings,” said Dr. Rex Tan, Chief Technology Officer of Aevice Health.
Aevice Health extends its heartfelt gratitude to its dedicated team and partners who have contributed to this achievement. The company remains committed to developing solutions that transform care delivery, reduce hospital readmissions, and improve quality of life for people living with chronic respiratory diseases.
About Aevice Health
Aevice Health is a digital health company dedicated to improving asthma and COPD care through its proprietary, non-invasive remote patient monitoring platform and wearable stethoscope, the AeviceMD. Its cutting-edge technology allows for continuous monitoring and real-time disease deterioration tracking, enabling patients to receive personalized care from the comfort of their homes. With actionable insights and effortless treatment response monitoring, healthcare professionals can make timely adjustments for optimized patient outcomes. Aevice Health is on a mission to improve healthcare accessibility, empower patients, and reduce healthcare costs.
More information about the company can be found at www.aevice.com.
For media enquiries, please contact:
Shanelle Ng
Aevice Health Pte Ltd
Email: shanelle@aevice.com
.png)
